[
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=d9ec922f37e29437dbf9c25bbf5384287506d9af3c558746f1f6e3c70e5a519b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734453240,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 132064989,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=d9ec922f37e29437dbf9c25bbf5384287506d9af3c558746f1f6e3c70e5a519b"
    }
  },
  {
    "ts": null,
    "headline": "4 Big Drug Stocks That May Continue to Outperform in 2025",
    "summary": "Gilead, Eli Lilly, Vertex Pharmaceuticals and AbbVie have outperformed the industry this year and are likely to see continued momentum in 2025.",
    "url": "https://finnhub.io/api/news?id=a277ac74285e35a4058bef9b5847ee67e8a6e3f755b62cdb97bbd019beb98daf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734447780,
      "headline": "4 Big Drug Stocks That May Continue to Outperform in 2025",
      "id": 132026658,
      "image": "https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Gilead, Eli Lilly, Vertex Pharmaceuticals and AbbVie have outperformed the industry this year and are likely to see continued momentum in 2025.",
      "url": "https://finnhub.io/api/news?id=a277ac74285e35a4058bef9b5847ee67e8a6e3f755b62cdb97bbd019beb98daf"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?",
    "summary": "AbbVie has a lofty goal for 2025 — and a big move in cancer treatment could stoke beleaguered AbbVie stock.",
    "url": "https://finnhub.io/api/news?id=c7b66840adb93cd5e54592fc314b7556eff571f6ae630c750021a02b4cf4d91b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734440445,
      "headline": "AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?",
      "id": 132025962,
      "image": "",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie has a lofty goal for 2025 — and a big move in cancer treatment could stoke beleaguered AbbVie stock.",
      "url": "https://finnhub.io/api/news?id=c7b66840adb93cd5e54592fc314b7556eff571f6ae630c750021a02b4cf4d91b"
    }
  }
]